Salary Range:CHF122,500.00 - CHF227,500.00 BandLevel 5 Job Description SummaryLocation: East Hanover NJ, US or Basel, Switzerland. This role will follow a hybrid working model. If based in US, please only apply to REQ-10080236 LI-#hybrid The Associate Director,
Idorsia Ltd is reaching out for more – We have more ideas, we see more opportunities and we want to help more patients. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Salary Range:CHF122,500.00 - CHF227,500.00 Job Description SummaryLI#- Hybrid Location: Basel, Switzerland At Novartis, we are reimagining medicine to improve and extend peoples lives. As a Senior Principal Scientist / Associate Director within Molecular & Cellular Sciences (MCS),
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of
Salary Range:CHF122,500.00 - CHF227,500.00 Job Description Summary#LI-Hybrid Location: Basel, Switzerland Are you ready to support some of the most important portfolio and development decisions at Novartis? As Associate Director, Portfolio Strategy & Operations, reporting to the Head
Salary Range:CHF142,100.00 - CHF263,900.00 Job Description SummaryThe Director, Portfolio Analytics leads major portfolio analytics workstreams that inform enterprise, franchise, TA, and senior leadership decisions. The role shapes analytical approaches, interprets portfolio-level implications, advises stakeholders on value